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Abstract
Experimental evidence indicates that exercise performed at different times of the day
may affect circadian rhythms and circadian disruption has been linked to breast and
prostate cancer. We examined in a population-based case-control study (MCC-Spain)
if the time-of-day when physical activity is done affects prostate and breast cancer
risk. Lifetime recreational and household physical activity was assessed by in-person
interviews. Information on time-of-day of activity (assessed approximately 3 years
after the assessment of lifetime physical activity and confounders) was available for
781 breast cancer cases, 865 population female controls, 504 prostate cases and
645 population male controls from 10 Spanish regions, 2008-2013. We estimated
odds ratios (ORs) and 95% confidence intervals (95% CI) for different activity timings
compared to inactive subjects using unconditional logistic regression adjusting for
confounders. Early morning (8-10 AM) activity was associated with a protective effect
compared to no physical activity for both breast (OR = 0.74, 95% CI = 0.48-1.15) and
prostate cancer (OR = 0.73, 95% CI = 0.44-1.20); meta-OR for the two cancers com-
bined 0.74 (95%CI = 0.53-1.02). There was no effect observed for breast or prostate
cancer for late morning to afternoon activity while a protective effect was also
observed for evening activity only for prostate cancer (OR = 0.75, 95% CI = 0.45-1.24).
Protective effects of early morning activity were more pronounced for intermediate/
evening chronotypes for both cancers. This is the first population-based investigation
identifying a differential effect of timing of physical activity on cancer risk with more
pronounced effects for morning hour activity. Our results, if confirmed, may improve
current physical activity recommendations for cancer prevention.
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1 | INTRODUCTION
Physical activity is an established protective factor for overall cancer
risk1-3 and for specific major cancers such as colorectal and breast
cancer. A recent meta-analysis on breast cancer reported an approxi-
mate 20% reduction in risk associated with physical exercise for both
premenopausal and postmenopausal women.4 Evidence for recrea-
tional physical activity and prostate cancer is less consistent although
long-term occupational physical activity seems to reduce prostate
cancer risk.5
Circadian disruption results when the endogenous circadian
rhythms are not in synchrony with environmental and social cues
such as light exposure, work hours, diet and activity patterns and
so forth. Exposure to artificial light at night, night shift work and
mistimed diet may interfere with the normal nocturnal melatonin
production and disrupt the circadian clock with numerous other
biological consequences.6-8 Both breast and prostate cancer have
been associated with different aspects of circadian disruption.
Night shift work has been linked to an elevated cancer risk particu-
larly in relation to breast and prostate cancer.7,8 In 2007 the Inter-
national Agency for Research on Cancer (IARC) classified shift work
which includes circadian disruption as probably carcinogenic to
humans (Group 2A)9 and a 2019 re-evaluation reached the same
conclusion.10 A diurnal pattern of diet has been associated with
lower prostate and breast cancer risk,11,12 while exposure to artifi-
cial light at night and particularly exposure to blue light spectrum
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light has been associated with higher breast and prostate cancer
risk.13,14
Chronotype is a human attribute that correlates with diurnal
preference for activities in the morning or evening.15 Diurnal pref-
erence and chronotype may affect adaptation of circadian
rhythms to new light-dark conditions dictated by the use of artifi-
cial light, such as light at night exposure in night shift workers or
light exposure and activity in the late evening/night due to a more
nocturnal lifestyle in the general population. In a recent general
population study examining circadian timings and chronotype,
morning types had the highest protection when following diurnal
patterns of diet compared to those having late supper (last eve-
ning meal).12
Mistimed physical activity could also disrupt circadian rhythms
and therefore affect cancer risk and other health outcomes. Women
doing less daily physical activity before noon (lowest quartile) had a
higher odds ratio (OR) for obesity (1.26, 95% CI 1.05-1.51) compared
to women doing more physical activity in the morning.16 To our
knowledge no study has investigated the timing of physical activity
during the day (24 hours period), circadian disruption and cancer risk.
We examined the effect of timing of recreational physical activity
on breast and prostate cancer risk in a population-based case-control
study and possible effect modification by chronotype and shift work.
We hypothesized that the beneficial effect of physical activity would
be less pronounced for evening physical activity compared to morning
activity.
2 | MATERIAL AND METHODS
2.1 | Study design, setting and population
MCC-Spain is a population-based case-control study that includes five
cancer types and 10 106 subjects (51.8% men).17 Data were collected
between September 2008 and December 2013 in 23 hospitals (cases)
and rosters of primary health care centers (controls) located in
12 Spanish provinces. For our study, we only considered breast (1738
cases) and prostate cancer (1112 cases) and 3403 population controls
frequency matched by sex, age and region of residence.
Cases were between 20 and 85 years old, diagnosed according to
the International Classification of Disease 10th Revision18 with female
breast cancer (C50, D05.1, D05.7) or prostate cancer (C61, D07.5).
Only histologically confirmed incident cases were included. Cases and
controls were residing in the catchment area of the hospital for at
least 6 months before the selection. Exclusion criteria were communi-
cation problems (mentally disabled, speech problems) and being physi-
cally disabled to participate in the study.
Incident cases were contacted at the hospitals while controls
were randomly selected from records of primary health care centers.
They were contacted by phone on behalf of their general practi-
tioners. For each case, there was at least one control of the same sex
and similar age (5-year interval) randomly chosen out of five possible
controls who were invited to a face-to-face interview. Response rates
were 71% for breast (1750/2465) and 72% for prostate cancer
(1115/1549) while 53% of the controls participated (4101/7743).
Rates were calculated using interviewed subjects in the numerator
and all subjects, including refusals, in the denominator.
For the current analyses, a sample of 5365 participants (breast
cases: 1438, female controls: 1593; prostate cases: 1004, male con-
trols: 1330) was used who had responded to the circadian timing
questionnaire (Figure 1). Response rates were similar for cases and
controls (breast cases: 82.7%, female control: 83.4%; prostate cases:
89.6%, male controls: 89.1%).
2.2 | Data sources and variables
A computerized questionnaire (the main questionnaire), was adminis-
tered by trained personnel in a face-to-face interview that took, on
average, 70 minutes (range: 30-130). Information was collected on
residential history, personal and family medical history,
sociodemographic factors, environmental exposures, occupational his-
tory, lifestyle (including all physical activity information used to esti-
mate lifetime physical activity levels) and quality of the interview.
Following the interview, anthropometric data and biological samples
were taken. Immediately after the in-person interview, a semiquanti-
tative Food Frequency Questionnaire (response rate: 88%) was given
to the participants, which was self-administered by most of the partic-
ipants; for a small percentage, an interviewer administered it when
participants were unable to do it themselves. The questionnaire was
based on a previously validated instrument in Spain.19 Between
6 months to 5 years (mean = 35 months [SD = 11]) later, breast and
prostate cancer cases and controls were contacted by telephone to
answer a circadian questionnaire including sleeping patterns, timing of
food intake and physical activity (type, time-of-day, and age at start
and end of activity), and more detailed information on shift work. Indi-
vidual chronotype was assessed through the same follow-up phone
interview using the Munich Chronotype Questionnaire (MCTQ).
What's new?
Exercise protects against a variety of cancers, but does time
of day matter? Disrupting the body's circadian rhythm can
boost cancer risk. Here, the authors compared breast and
prostate cancer risk among people who exercised in the early
morning, late morning, afternoon, and evening. They con-
ducted a population-based case-control study, in which par-
ticipants filled out a questionnaire about their patterns of
sleeping, eating, and exercising. Exercising in the early morn-
ing appeared to be more strongly protective against breast
and prostate cancer than exercising later in the day. Evening
exercise appeared to have a moderate protective effect on
prostate cancer.
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Clinical information was collected from medical records including
tumor hormonal receptor status, differentiation grade and histological
type. Breast cancer cases were classified in three subtypes according
to hormonal receptors20,21 (a) Progesterone receptor (PR) positive
and/or estrogen receptor (ER) positive with luminal human epidermal
growth factor receptor 2 (HER2) negative; (b) HER+ irrespective of PR
and ER type; (c) triple negative with PR−, ER− and HER−. Prostate
cancer cases were classified according to their biopsy Gleason score
(a: Score ≤ 6; b: Score > 6). We did not use the latest grading system22
for the Gleason score because of a low sample size in some
subgroups.
In the main and circadian questionnaire, participants reported
every recreational physical activity done continuously for at least
6 months, throughout lifetime (from 5 years of age onward). The fol-
lowing question was used: “We are going to ask you about any physical
activity done outside working hours, including walking, any exercise, going
to the gym, etc. We are interested in any physical activity you did contin-
uously and for at least six months throughout your life. What activity do
you do, or did you use to do?” For each reported activity, a value of
metabolic equivalents (METs) was assigned according to the
Ainsworth's Compendium of Physical Activities.23 Furthermore,
the duration of the activity through lifetime was estimated using the
information on age, start and end of activity. In the main, but not in
the circadian questionnaire, the frequency (h/week) of each activity
was also assessed. For the analysis based on information provided in
the circadian questionnaire, the timing pattern of the longest recrea-
tional activity done in lifetime for each person was chosen. For the
sensitivity analysis the pattern of the timing for the most strenuous
recreational activity done in lifetime was estimated. The most strenu-
ous activity was defined as the activity with the highest METs
assigned according to the Ainsworth's Compendium independent of
the duration of the activity. Based on information provided in the
main questionnaire we considered people as physically active in their
lifetimes if they had done more than 1 MET * h/week as an annual
average from 5 years of age onward with a lag of 1 year to the year of
the interview. Only this variable, lifetime physical activity, was based
on responses in the main questionnaire. All other physical activity var-
iables in the present analysis are based on answers to the circadian
questionnaire. After asking for the type of activity the following
question was used to assess the time-of-day of activity: “At what time
do you do, or did you use to do this activity?”. The available response-
categories were early morning (8-10 AM), late morning (10-12 AM),
midday (12-3 PM), afternoon (3-7 PM), evening (7-11 PM), night
(11 PM-8 AM), “no pattern” and “does not know.” Categories were non-
exclusive. Using these categories and taking into account frequency in
each category a physical activity exposure variable was created using
inactive people as the reference group: inactive, early morning
(8-10 AM), late morning (10 AM-12 PM), midday to afternoon (12-7 PM),
evening (7-11 PM) and other pattern (every other time or combination
of times).
We considered as potential confounders age, education (a, less
than primary school; b, primary school; c, secondary school; d, univer-
sity), region of residence, tobacco consumption, obesity (body mass
index [BMI] > 30), lifetime physical activity (average METs/week from
5 years of age onwards with a lag of 1 year to the year of the inter-
view), and duration, intensity, and age at start and end of the longest
(or most strenuous) activity. For women, additional possible con-
founders were menopausal status, defined as absence of menstrua-
tion during the last year, family history of breast cancer, age at
menopause and menarche, estrogen intake, parity, age at first birth,
and for men, ethnicity. Night work10 (a, Never night work: always day
work + rotating no nights; b, night work: permanent night work
+ rotating night work; c, no work outside home) and chronotype
(morning type, intermediate type, evening type11) were considered
possible effect modifiers.
2.3 | Final study population
Of the 5365 initial participants, 2795 respondents (52.1%) had full
information on their activity pattern, lifetime physical activity, and key
confounders age, education and region of residence (781 breast cases
(54.3%), 865 female controls (54.3%) and 504 prostate cases (50.2%),
645 male controls (48.5%)) (Figure 1).
Respondents were slightly younger (respondent: median = 62,
IQR: 52-69; nonrespondent: median = 64, IQR: 54-72), more likely to
be female (respondent: 58.9% women; nonrespondent: 54.0%) and
had a better education (respondent: 85.2% at least primary education;
Main data set (N = 6253)
1738 breast cancer cases and 1910 controls
1112 prostate cancer cases and 1493 controls
Main data set + timing data set (N = 5365)
1438 breast cancer cases and 1593 controls
1004 prostate cancer cases and 1330 controls
Main data set + full timing information (N = 2795)
Did not answer circadian questionnaire (N = 888)
300 breast cancer cases and 317 controls
108 prostate cancer cases and 163 controls
781 breast cancer cases and 865 controls
504 prostate cancer cases and 645 controls
Missing data in the timing or lifetime physical
activity variable (N = 2570)
657 breast cancer cases and 728 controls
500 prostate cancer cases and 685 controls
F IGURE 1 Flow chart describing
exclusions and final sample size
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nonrespondent: 79.7%). In addition to missing data in the activity pat-
tern, there were 31 subjects with missing values for chronotype,
35 for night work, eight for smoking status, 51 for family history of
breast cancer, 50 for family history of prostate cancer, 74 for breast
cancer subtype and six for Gleason score. Participants with missing
values in these variables were not excluded to avoid reducing the
sample size. However, they were excluded in the sensitivity analyses.
2.4 | Statistical methods
A full-case analysis was conducted including subjects without missing
values (N = 2795 [52.1%]) for the main exposure and key confounders
(age, region of residence and education). Inclusion of confounders in
the models was based on a priori DAGs and change of effect esti-
mates (≥10%). The covariates ethnicity, tobacco consumption, age at
menopause and menarche, estrogen intake, and age at first birth did
not change effect estimates. We estimated ORs with 95% confidence
intervals using unconditional logistic regression. We adjusted for the
frequency-matched variables age (continuous) and region of residence
(Madrid; Barcelona; Navarra; Guipuzcoa; Leon; Asturias; Huelva;
Cantabria; Valencia; Granada; Gerona) for each cancer type sepa-
rately, education (less than primary school; primary school; secondary
school; university), and in women for menopausal status
(premenopausal or postmenopausal) and family history of breast can-
cer (no family history of breast cancer; first degree relative; second
degree relative; other degree relative). We also adjusted for lifetime
average METs * h/week (continuous), METs (low: ≤4; intermediate:
>4 and ≤6; high: >6), duration (continuous), and age at start and end
of the longest done activity in lifetime (continuous), BMI (continuous),
energy intake (kcal/day), and in women for parity (nulliparous: yes, no)
in separate models. Combined cancer risk for breast and prostate can-
cers were calculated using STATA's metan function.
Analysis in subphenotypes was done for breast cancer hormone
receptor types (hormone receptor positive, HER+ and triple negative),
in premenopausal and postmenopausal women, and for prostate can-
cer according to the Gleason score (≤6 and >6). In addition, we ran
stratified models for chronotype and night work to examine effect
modification. We tested for multiplicative interactions with cross-
product terms and Wald test, and for additive interactions estimating
RERI with STATA's lincom command.
Sensitivity analyses were conducted in participants without missing
values in the variables (METs, age at start and end, duration of longest activ-
ity done in lifetime, lifetime annual average METs * h/week, parity, BMI and
total energy intake) comparing the models with basic adjustment (age, region,
education and for women menopausal status and family history of breast
cancer) to models with additional adjustment (METs, age at start and end,
duration of longest activity done in lifetime, lifetime annual average
METs * h/week, parity, BMI and total energy intake). Furthermore, sensitivity
analyses were conducted for all models a second time for the activity pattern
of the most strenuous activity done in lifetime. In addition, we ran the main
models again examining a category that included to the early morning group
those who used to be active in the early morning and also at any other time
of day. Due to missing values (170 in women and 24 in men) in the
variables chronotype, night work, family history of breast cancer,
breast cancer subtype and Gleason score we ran the main models
again, restricted to participants without missing values in these var-
iables. In further sensitivity analyses we set the activity threshold
to >0.5 and >2.0 METs * h/week as an annual average to investi-
gate how this would affect our results. We finally examined
whether other circadian related variables (sleep and time of dinner-
last main meal) confounded the association of timing of physical
activity with cancer. For all analysis the level of significance was set
at two-sided P < .05 and STATA (version 14.1, 2015, StataCorp LP)
was used.
3 | RESULTS
3.1 | Study population characteristics
Breast cancer cases were younger than controls, more active in the
evening (7-11 PM) and had a higher percentage of night work and first-
degree family history of breast cancer. Prostate cancer cases were less
educated, had a higher percentage of night work and first-degree fam-
ily history of prostate cancer and were more active in the late morning
(10 AM-12 PM) and afternoon (3-7 PM) compared to controls (Table 1).
One hundred and twenty-nine men (11.2%) and 275 women
(16.7%) reported a lifetime annual average of 1 MET * h/week.
Overall, being more active through lifetime was moderately associ-
ated (after adjusting for age and education) with a reduction in
prostate (OR = 0.85, CI 95% = 0.57-1.26) while no or a minimal
effect was observed for breast cancer risk (OR = 0.97, 95%
CI = 0.74-1.26).
Concerning the longest done physical activity in lifetime, the most
frequently reported activities were walking (47.6%), going to the gym
(10.3%), swimming (7.2%), soccer (4.3%), riding the bike (3.6%), other
intermediate intensity activities equal to 4.5 METs (3.4%) and house-
hold chores, gardening, dancing, excursions, playing tennis and other
low intensity activities equal to 3 METs (2%, respectively). Subjects
active in the early morning were more likely to engage in swimming or
riding the bike compared to the other groups. Walking and other low
intensity activities were more frequent in subjects active in the late
morning. Going to the gym, playing soccer, dancing, playing tennis and
other intermediate intensity activities were more frequent in subjects
active in the evening. The most frequently reported time-of-day of
activity was the late morning (10 AM-12 PM) and evening (7-11 PM)
(Table 1).
Most subjects were adults (median age = 38, IQR: 20-54) when
they began their longest-achieved activity in lifetime and stopped
when becoming older adults (median age = 59, IQR: 46-67). Breast
cancer cases began their longest-achieved activity at a similar time in
life (median age = 35, IQR: 20-46) compared to female controls
(median age = 35, IQR: 20-50) but stopped slightly earlier in life
(median age = 53, IQR. 44-62) than female controls (median age = 56,
IQR: 45-66). Prostate cancer cases and male controls began (case:
WEITZER ET AL. 5
TABLE 1 Descriptive characteristics of breast and prostate cancer cases and controls with a valid register of their activity pattern for the
longest done physical activity in lifetime
Breast cancer
cases (N = 781)
Breast cancer
controls (N = 865)
Prostate cancer
cases (N = 504)
Prostate cancer
controls (N = 645)
N (%) N (%) N (%) N (%)
Age (years); mean(SD) 55.3 (11.2) 58.2 (12.5) 65.9 (6.9) 65.9 (8.8)
Obesity 123 (15.7) 146 (16.9) 113 (22.4) 141 (21.9)
Education
Less than primary school 88 (11.3) 157 (14.0) 122 (24.2) 94 (14.6)
Primary school 247 (31.6) 344 (30.4) 201 (39.9) 208 (32.2)
Secondary school 274 (35.1) 371 (32.8) 112 (22.2) 200 (31.0)
University 172 (22.0) 258 (22.8) 69 (13.7) 143 (22.2)
Smokinga
Never 424 (54.6) 495 (57.3) 146 (29.1) 187 (29.1)
Current 175 (22.5) 181 (21.0) 109 (21.7) 127 (19.7)
Exsmoker 178 (22.9) 188 (21.7) 247 (49.2) 330 (51.2)
First degree family history of breast/
prostate cancerb
112 (14.3) 82 (9.5) 94 (18.7) 42 (6.5)
Chronotypec
Morning 295 (38.2) 312 (36.3) 249 (49.5) 320 (50.9)
Intermediate 301 (39.0) 356 (41.4) 175 (34.8) 232 (36.9)
Evening 176 (22.8) 192 (22.3) 79 (15.7) 77 (12.2)
Night workd 111 (14.5) 100 (11.9) 164 (32.6) 179 (27.8)
Menopause
Premenopausal 275 (35.2) 262 (30.3) NA NA
Postmenopausal 506 (64.8) 603 (69.7) NA NA
Physical activity pattern
Inactive 132 (16.9) 143 (16.5) 62 (12.3) 67 (10.4)
Early morning (8-10 AM) 55 (7.0) 78 (9.0) 64 (12.7) 90 (14.0)
Late morning (10 AM-12 PM) 140 (17.9) 168 (19.4) 103 (20.4) 98 (15.2)
Midday (12-3 PM) 20 (2.6) 15 (1.7) 7 (1.4) 17 (2.6)
Afternoon (3-7 PM) 101 (12.9) 110 (12.8) 35 (6.9) 31 (4.8)
Evening (7-11 PM) 132 (16.9) 128 (14.8) 63 (12.5) 101 (15.7)
Night (11 PM-8 AM) 2 (0.3) 7 (0.8) 4 (0.8) 6 (0.9)
No patterne 91 (11.7) 86 (10.0) 60 (12.0) 105 (16.2)
Other patterne 108 (13.8) 130 (15.0) 106 (21.0) 130 (20.2)
Lifetime annual average of METs * h/week
≤1 MET 132 (16.9) 143 (16.5) 62 (12.3) 67 (10.4)
to 7.9 METs 334 (42.8) 434 (50.2) 204 (40.5) 274 (42.5)
8 to 16 METs 163 (20.9) 145 (16.8) 104 (20.6) 133 (20.6)
>16 METs 152 (19.4) 143 (16.5) 134 (26.6) 171 (26.5)
Abbreviation: NA, not applicable.
aMissing for four breast cancer cases (0.5%) and one control (0.1%); two prostate cancer cases (0.4%) and one controls (0.16%).
bMissing for 18 breast cancer cases (2.3%) and 33 controls (3.8%); 16 prostate cancer cases (3.2%) and 43 controls (5.2%).
cMissing for nine breast cancer cases (0.1%) and five controls (0.5%); one prostate cancer case (0.2%) and 16 controls (2.5%).
dMissing for 13 breast cancer cases (1.7%) and 21 controls (2.44%); one prostate cancer case (0.2%).
eIn the no pattern category participants indicated having no pattern while the other pattern category includes all patterns that did not exactly match with
the above mentioned categories.
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median age = 43.5, IQR: 20-60; control: median age = 43.5, IQR:
20-60) and stopped their longest-done activity at a similar age (case:
median age = 64, IQR:53-69; control: median age = 64, IQR: 50-70)).
3.2 | Effect of timing of physical activity of the
longest done physical activity in lifetime
Early morning (8-10 AM) activity was associated with a protective
effect compared to no physical activity for both breast (OR = 0.74,
0.48-1.15) and prostate cancer (OR = 0.73, 0.44-1.20) but confidence
intervals were wide. The meta-OR for the two cancers combined for
early morning exercise was 0.74 (0.53-1.02). There was no effect
observed for breast or prostate cancer for late morning or midday to
afternoon physical activity while a moderate protective effect was
also observed for evening physical activity but only for prostate can-
cer (OR = 0.75, 0.45-1.24). Male subjects with other patterns includ-
ing both morning, evening and night activity, showed also a protective
pattern similar to morning physical activity (OR = 0.79, 0.52-1.21)
(Table 2).
When conducting the analyses using participants who had com-
plete data on additional confounders, adjustment for METs (two miss-
ings), age at start and end, and duration of longest activity done in
lifetime (60 missings), lifetime annual average METs * h/week, parity
(one missing), BMI and total energy intake (232 missings) only minor
changes in the ORs were found as compared to the previous analyses
that had adjusted for age, education, region and for women also men-
opause and family history (Supporting Information Table 1).
3.3 | Modification by chronotype and night work
For breast cancer, the protective effect of early morning activity was
more pronounced among intermediate and evening chronotypes with
ORs of 0.55 (0.25-1.20) and 0.53 (0.14-1.99) respectively, although
the number of subjects in some strata was very small (Table 3). The
same pattern was observed for prostate cancer (intermediate:
OR = 0.64, 0.27-1.56; evening: OR = 0.45, 0.09-2.15) but confidence
intervals were wide. For breast cancer, ORs for physical activity
among evening types were generally low irrespective of the time of
the day of the activity (Table 3).
Additional adjustment for other potential confounding factors,
did not alter the overall risk pattern although it led to a similar effect
of early morning activity in women with an early or intermediate chro-
notype (Supporting Information Table 2). This difference was mainly
due to the change (reduction) in the number of subjects because of
the exclusion of subjects with missing values rather than to an
effect of adjustment. Additional adjustment, however, did seem to
reduce risk differences across time-of-day in men with an early
chronotype.
Similar effects were found in people who never worked at night, with
the most consistent effects observed for early morning activity for both
breast (OR = 0.70, 95% CI = 0.42-1.14) and prostate cancer (OR = 0.61,
95% CI = 0.34-1.09) (Supporting Information Table 3). Results for other activ-
ity times were similar to those found for all subjects (Table 2, Supporting
Information Table 3). Effect modification by chronotype and night work was
not statistically significant, neither on a multiplicative nor on an additive scale.
Furthermore, chronotype and night work did not confound the association
between time-of-day of physical activity and cancer risk.
3.4 | Subphenotype analysis
When analyzing clinical subgroups in breast cancer (Table 4) early
morning (8-10 AM) activity seemed to be protective for the estrogen/
progestogen receptor positive and the HER+ subgroup. Triple nega-
tive breast cancer risk was similar across categories of physical activity
timing. The moderate protective effect of early morning activity
TABLE 2 Association of breast and prostate cancer with timing of the longest done physical activity in lifetime
Breast cancer





cases (N = 504)
Prostate cancer
controls (N = 645)
N (%) N (%) OR (95% CI)a,b N (%) N (%) OR (95% CI)a
Inactive 132 (16.9) 143 (16.5) 1 62 (12.3) 67 (10.4) 1
Early morning
(8-10 AM)
55 (7.0) 78 (9.0) 0.74 (0.48–1.15) 64 (12.7) 90 (14.0) 0.73 (0.44-1.20)
Late morning
(10 AM-12 PM)




121 (15.5) 125 (14.5) 1.03 (0.72-1.47) 42 (8.3) 48 (7.4) 1.11 (0.45-1.23)
Evening
(7-11 PM)
132 (16.9) 128 (14.8) 1.10 (0.77-1.57) 63 (12.5) 101 (15.7) 0.75 (0.45–1.24)
Other patternc 201 (25.7) 223 (25.8) 0.96 (0.70-1.32) 170 (33.7) 241 (37.4) 0.79 (0.52-1.21)
aAdjusted for age, education and region.
bFurther adjusted for menopause and family history of breast cancer (51 missing, missing for 18 breast cancer cases (2.3%) and 33 controls (3.8%).
cIncludes all participants active during the night (11 PM-8 AM), who had no pattern or another pattern (see Table 1).
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tended to be stronger for postmenopausal women compared to
premenopausal women. (Table 4).
In subtype analysis, the effects were similar between clinical sub-
types of prostate cancer (Gleason score ≤ 6 vs Gleason score 7 or higher)
with a moderate protective effect observed for early morning and eve-
ning activity (Table 5), similar to the overall effect (Table 2). However,
the protective effect of early morning physical activity tended to be
slightly stronger for aggressive tumors (Gleason score 7 or higher).
3.5 | Sensitivity analyses
The analysis of the most strenuous activity done in lifetime instead of
the longest activity lead to similar results in women but not in men.
(Supporting Information Table 4). When setting the activity threshold
to >0.5 METs * h/week risk estimates were lower across all timing
categories (Supporting Information Table 5), being more active (after
adjusting for age and education) was associated with lower cancer risk
(breast cancer: OR = 0.89, 95% CI = 0.64-1.24; prostate cancer:
OR = 0.88, 95% CI = 0.55-1.40). When setting it to >2.0 METs * h/
week estimates were higher (Supporting Information Table 6), being
more active was not associated with a lower cancer risk (breast can-
cer: OR = 1.24; 95% CI = 0.99-1.53; prostate cancer: OR = 1.05, 95%
CI = 0.78-1.42). Nonetheless, early morning activity was always linked
to the strongest protective effect in women. The same applied for
early morning and evening activity in men. Examining a category that
included in the morning group those who used to be active in the
early morning and also at any other time of day, revealed the same













N (%) N (%) OR (95% CI)a,b N (%) N (%) OR (95% CI)a
Morning chronotype
Inactive 50 (17.0) 50 (16.0) 1 27 (10.8) 35 (10.9) 1
Early morning
(8-10 AM)
35 (11.9) 38 (12.2) 0.96 (0.51-1.83) 40 (16.1) 55 (17.2) 0.92 (0.46-1.83)
Late morning (10 AM-
12 PM)
52 (17.6) 59 (18.9) 0.96 (0.54-1.72) 41 (16.5) 50 (15.6) 0.97 (0.47-2.00)
Midday to afternoon
(12-7 PM)
36 (12.2) 45 (14.4) 0.85 (0.46-1.58) 17 (6.8) 25 (7.8) 1.01 (0.44-2.33)
Evening (7-11 PM) 39 (13.2) 41 (13.1) 0.89 (0.47-1.69) 35 (14.1) 44 (13.8) 1.14 (0.56-2.34)
Other patternc 83 (28.1) 79 (25.3) 1.15 (0.68-1.97) 89 (35.7) 111 (34.7) 1.05 (0.57-1.93)
Intermediate chronotype
Inactive 43 (14.3) 62 (17.4) 1 25 (14.3) 24 (10.3) 1
Early morning
(8-10 AM)
14 (4.6) 32 (9.0) 0.55 (0.25–1.20) 18 (10.3) 24 (10.3) 0.64 (0.27–1.56)
Late morning (10 AM-
12 PM)
62 (20.6) 73 (20.5) 1.36 (0.77-2.39) 45 (25.7) 34 (14.7) 1.31 (0.60-2.83)
Midday to afternoon
(12-7 PM)
52 (17.3) 47 (13.2) 1.55 (0.86-2.80) 12 (6.9) 16 (6.9) 0.82 (0.30-2.22)
Evening (7-11 PM) 55 (18.3) 49 (13.8) 1.52 (0.84-2.77) 17 (9.7) 39 (16.8) 0.48 (0.20-1.17)
Other patternc 75 (24.9) 93 (26.1) 1.02 (0.60-1.73) 58 (33.1) 95 (41.0) 0.63 (0.32-1.26)
Evening chronotype
Inactive 37 (21.0) 30 (15.6) 1 9 (9.4) 7 (9.1) 1
Early morning
(8-10 AM)
5 (2.8) 8 (4.2) 0.53 (0.14–1.99) 7 (7.3) 9 (11.7) 0.45 (0.09-2.15)
Late morning (10 AM-
12 PM)
26 (14.8) 35 (18.2) 0.09 (0.23-1.10) 22 (22.9) 12 (15.6) 1.20 (0.31-4.64)
Midday to afternoon
(12-7 PM)
33 (18.8) 33 (17.2) 0.65 (0.31-1.39) 15 (15.6) 6 (7.8) 2.22 (0.48-10.3)
Evening (7-11 PM) 37 (21.0) 36 (18.8) 0.87 (0.42-1.78) 14 (14.6) 17 (22.1) 0.46 (0.11-1.87)
Other patternc 38 (21.6) 50 (26.0) 0.55 (0.27-1.11) 29 (30.2) 26 (33.7) 0.67 (0.19-2.32)
aAdjusted for age, education and region.
bFurther adjusted for menopause and family history of breast cancer (51 missing, missing for 18 breast cancer cases (2.3%) and 33 controls (3.8%)).
cIncludes all participants active during the night (11 PM-8 AM), who had no pattern or another pattern (see Table 1).
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pattern as found in the main analysis, although less pronounced
(Supporting Information Table 7). Restricting the models to partici-
pants who did not have missing values in the variables chronotype,
night work, family history of breast cancer, breast cancer subtype and
Gleason score did not change effect estimates (Supporting Informa-
tion Table 8).
We finally examined whether other circadian related variables,
specifically sleep and timing of dinner (last main meal) could confound
the association of timing of physical activity with cancer risk. To eval-
uate confounding we limited the analysis to those without missing
values, and adjusted for sleep duration (in hours, <7, 7-8, >8) and for
time of dinner (≤9:30 PM, >9:30 PM—the median dinner time in this
population). The ORs not adjusting for sleep or timing of diet are com-
parable to those in Table 2 with minor differences because of the
change in the numbers. There was no confounding by sleep or timing
of dinner with minimal changes in the ORs (Supporting Information
Table 9).
4 | DISCUSSION
In the present study, we observed that the overall protective effect of
recreational and household physical activity for cancer may vary
depending on the time of the day of the activity. We found that early
morning activity might be more protective than late morning-
afternoon activity for both breast and prostate cancer risk. Findings
on evening activity differed with a moderate protective effect
observed only for prostate cancer. There was no consistent pattern
by chronotype, and differences were observed in tumor sub-
phenotypes. The biological pathways associated with a differential
effect of physical activity during the day are unclear and may be
related to circadian hormonal patterns.
Mean lifetime physical activity levels were very low in the present
study compared to other populations24-26 and this complicates com-
parison of our results to other research. Most other studies compared
participants who did not do any physical activity to participants who
did any physical activity or compared the least active to the most
active quartile.4,5,24-26 In contrast, participants in our reference group
reported some activity throughout their lifetime. To our knowledge
there is no other study that investigated the time-of-day of activity in
relation to cancer risk. However, some evidence already exists on
activity at different ages in life and cancer risk.27
Timing of physical activity has been associated with changes in
physiological parameters related to circadian rhythms. In one experi-
ment, evening exercise delayed the falling phase of the circadian
rhythm of plasma melatonin in men, reduced rapid eye movement
sleep, slowed down the decline of rectal temperature and accelerated
the heart rate during the sleep of the following night. Morning exer-
cise increased the number of heart waves during the sleep. This could
indicate that morning exercise stimulates parasympathetic activity,
while evening exercise promotes sympathetic activity during the fol-
lowing night sleep.28 Another study reported significantly higher
plasma interleukin(IL)-6 and adrenaline levels in men after evening
exercise (5-6 PM) compared to morning exercise (9-10 AM).29 IL-6, a
pleiotropic cytokine, has anti-inflammatory (cis signaling) and
proinflammatory characteristics (trans signaling)30 and during and
after exercise IL-6 has positive effects.31,32 Morning exercise was
associated with a lower number of sleep stage-shifts over the whole
night and a lower number of wake stages during the second half of
the night.33 A later peak of the body temperature rhythm (acrophase
delay) and a lower amplitude (smaller difference between the peak
and the mean value of the wave of the circadian rhythm) was reported
in an evening exercise group (9 PM) compared to morning exercise
(9 AM).34 This evidence hints toward an effect of time-of-day of physi-
cal activity on circadian disruption which was linked to
tumorigenesis.35
In our study, the moderate protective effect of breast cancer
associated with early morning activity compared to evening activity
may be related to a different effect of timing of physical activity on
sex steroid production. Higher levels of estrogens are associated with
TABLE 4 Association (OR, 95% CI) between breast cancer and timing of the longest done physical activity in lifetime by menopausal status












Inactive 1 1 1 1 1
Early morning (8-10 AM) 0.76 (0.46-1.26) 0.37 (0.15-0.93) 1.33 (0.42-4.13) 0.93 (0.43-1.98) 0.62 (0.35-1.09)
Late morning (10 AM-12 PM) 1.05 (0.71-1.55) 0.60 (0.31-1.16) 1.28 (0.49-3.34) 0.90 (0.44-1.85) 1.04 (0.69-1.56)
Midday to afternoon
(12-7 PM)
1.06 (0.71-1.60) 0.73 (0.37-1.42) 1.19 (0.43-3.28) 1.26 (0.67-2.37) 0.94 (0.60-1.47)
Evening (7-11 PM) 1.31 (0.88-1.97) 0.73 (0.38-1.41) 1.17 (0.41-3.34) 0.96 (0.54-1.72) 1.19 (0.74-1.93)
Other patternd 1.09 (0.76-1.57) 0.70 (0.39-1.25) 0.84 (0.31-2.23) 0.77 (0.43-1.37) 1.04 (0.70-1.55)
aAdjusted for age, education and region.
bFurther adjusted for menopause.
cFamily history of breast cancer (51 missing, missing for 18 breast cancer cases (2.3%), and 33 controls (3.8%)).
dIncludes all participants active during the night (11 PM-8 AM), who had no pattern or another pattern (see Table 1).
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increased breast cancer risk.36 Physical activity is associated with
lower estrogen levels37 and the estradiol production peaks around
7 AM.38 Morning activity compared to evening activity might reduce
estradiol levels shortly after the morning peak of the cycle. This
approach could also explain why early morning activity does not seem
to be more protective than evening activity for the triple negative
breast cancer subtype, since it is estrogen and progesterone hormone
factor negative. There are no prior studies examining the time-of-day
effect of physical activity on sex steroids but in a previous study we
found increased progestogen levels in night workers compared to day
workers.39
Effects of physical activity on melatonin levels could also provide
clues for a differential effect of time-of-day of activity and the protec-
tive effect of early morning activity. Melatonin has a broad variety of
anticarcinogenic effects40 and noon and/or afternoon exercise were
shown to delay the on-set and acrophase (peak) of the melatonin
rhythm.41 Thus, late midday to afternoon (12-7 PM) compared to early
morning (8-10 AM) activity could delay the onset and peak of melato-
nin production and may lead to a shorter period of melatonin produc-
tion and reduced melatonin levels. Melatonin is also known to reduce
estrogen levels,42 and therefore light induced or physical activity
induced suppression of melatonin may in turn lead to increased sex
steroid levels. Therefore, melatonin may mediate some of the
suggested effects of physical activity on sex hormone production. Fur-
thermore, the peak level of the melatonin rhythm decreases with
age.43 The delaying effect of afternoon and noon exercise on the mel-
atonin rhythm could therefore have a stronger effect in older people;
however, the cancer risk related to midday-afternoon activity did not
seem bigger in postmenopausal women and for prostate cancer with a
Gleason score of 7 or higher.
The protective effect of early morning compared to midday to
afternoon activity was stronger in intermediate and late chronotypes.
The later onset of melatonin production in intermediate and late chro-
notypes44 could be perhaps affected to a greater extend by midday to
afternoon exercise, leading to a larger reduction of melatonin produc-
tion because its synthesis is limited by daylight in the morning.45 Last,
the discrepancy between the effect of evening activity on breast and
prostate cancer risk could also be explained by melatonin rhythm dis-
ruption. Yamanaka et al28 report a delay of the falling phase of the
melatonin rhythm in men after exercise in the evening. This delay
might ultimately lead to a higher overall production of melatonin and
consequently reduce cancer risk.
Obesity has been associated with both breast and prostate cancer
and may be an additional pathway through which physical activity and
timing of physical activity may be associated with lower cancer risk.
Higher weight loss46 and lower total calorie consumption47 have been
observed among persons doing morning exercise compared to exer-
cise in other hours of the day. However, in our analysis, adjusting for
BMI and total calorie consumption did not change the cancer risk pat-
tern by timing category.
Major strengths of the study are the population-based design and
the large sample size. Loss of statistical power due to missing values
and exposure misclassification are the main limitations of the study.
For all risk estimates confidence intervals were wide and numbers
were small in stratified analyses. Only lifetime recreational and house-
hold physical activity was considered, mainly done during adulthood.
Occupational physical activity was not assessed, and results might
therefore be confounded. We did not analyze household and recrea-
tional activity separately although they might have a differential effect
on cancer risk. Misclassification of exposure may have occurred due
to inherent difficulties in evaluating physical activity in epidemiologic
studies.48 This type of bias typically tends to attenuate findings and
may have been even more pronounced in the evaluation of timing of
activity. The threshold for inactivity in lifetime was set at a very low
level (1 MET * h/week as annual average) and was selected to ensure
a sufficient group size for the reference and exposure groups in analy-
sis. Although the overall risk pattern (eg, morning activity more pro-
tective than afternoon activity) did not disappear when using a
different inactivity threshold in sensitivity analyses, effect estimates
did change. In addition, because we tested a novel hypothesis, there is
limited knowledge on measurement of the main exposure variable
(timing of activity patterns). Although the questionnaire used was
detailed, the validity of the questions is not known, nor is its repeat-
ability in different populations. We collected timing of physical activ-
ity information on average 35 months (SD = 11) after the
administration of the main questionnaire. Given the good prognosis of
both cancers, it is unlikely that this may have resulted to biased results
due to selective cancer survival due to physical activity. However,
recall bias and reverse causation could have biased our results and
results should therefore be interpreted with caution. Finally, we did
not control for two potential confounders, diet and sleep patterns.
Overall our findings indicate that time of the day of physical activ-
ity is an important aspect of physical activity that may potentiate the
protective effect of physical activity on cancer risk. The effect of
timing of physical activity on cancer risk should be examined in future
research with a more detailed assessment of activity patterns, also
including occupational activity. More evidence on biological
TABLE 5 Association (OR, 95% CI) between prostate cancer and
timing of the longest done physical activity in lifetime by Gleason
score (N = cases)
Gleason score ≤ 6
(N = 237)a





0.80 (0.43-1.47) 0.69 (0.37-1.29)
Late morning (10 AM-
12 PM)
0.89 (0.48-1.63) 1.32 (0.74-2.36)
Midday to afternoon
(12-7 PM)
1.14 (0.56-2.31) 1.06 (0.52-2.15)
Evening (7-11 PM) 0.71 (0.38-1.32) 0.79 (0.42-1.49)
Other patternb 0.87 (0.52-1.45) 0.69 (0.41-1.17)
aAdjusted for age, education and region.
bIncludes all participants active during the night (11 PM-8 AM), who had no
pattern or another pattern (see Table 1).
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mechanisms of how timing of physical activity influences circadian
rhythms is needed and the proposed mechanisms regarding the
potential effect of timing on cancer risk should be further examined.
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